We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Gelkant (Chengdu) Biotechnology Co., LTD., established in June 2020, is an international research enterprise integrating R&D, production and sales. The company focuses on the field of health medicine, mainly engaged in the research and development of high value-added apis and matching pharmaceutical intermediates as well as process optimization, biochemical ligands and innovative drug research in the field of segmentation. The company has a leading domestic research and development platform for new pharmaceutical intermediates and apis, equipped with advanced instruments and equipment, and perfect and accurate analysis and testing system. At the same time, the company also carries out technology transfer and technical services in the field of segmentation. At present, the company has signed a joint research and development laboratory platform co-construction agreement with well-known universities and enterprises in the country to carry out various technical cooperation.
With good product quality control system and competitive prices, the company has established cooperative relations with pharmaceutical enterprises in North America, Europe, Japan, South Korea, India and other regions. At present, it has cooperated with the world's top 22 pharmaceutical enterprises and domestic famous pharmaceutical and research and development enterprises.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![Dichloro[bis(1,3-diphenylphosphino)propane]palladium(II)](https://eimg.pharmasources.com/image/product/20240115/b68105efe5e8018fbe64a10e418834f9jpg!145)
